Table 2.
p53 expression | ||||
---|---|---|---|---|
Total | Low | High | p value | |
Age | ||||
< 55 yrs | 18 | 13 | 5 | n.s. |
≥55 yrs | 18 | 12 | 6 | |
ER expression | ||||
Negative | 14 | 8 | 6 | n.s. |
Positive | 22 | 17 | 5 | |
PgR expression | ||||
Negative | 13 | 9 | 4 | n.s. |
Positive | 23 | 16 | 7 | |
Grading# | ||||
G2 | 21 | 17 | 4 | n.s. |
G3 | 15 | 8 | 7 | |
Stage*° | ||||
I-IIA | 17 | 15 | 2 | 0.02 |
IIB-III | 16 | 7 | 9 | |
HER2 | ||||
Negative" | 27 | 21 | 6 | n.s. |
Positive" | 9 | 4 | 5 | |
Ki67 | ||||
Negative | 22 | 15 | 7 | n.s. |
Positive | 14 | 10 | 4 | |
Treatment response | ||||
CR+PR | 15 | 11 | 4 | n.s. |
SD+PD | 21 | 14 | 7 |
n.s. = not significant; CR = complete response; PR = partial response; SD = stable disease; PD = disease progression. #According to Elston and Ellis classification (Ref. 31). *According to UICC-TNM classification of malignant tumours, sixth edition 2002 (Ref. 30). °At initial diagnosis time. "IHC 0,1+ and 2+ FISH negative were regarded as negative while IHC 3+ or 2+ FISH positive were regarded as positive.